PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Apr-2026 Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting Businesswire
21-Apr-2026 Convergent Therapeutics to Present Phase 2 Data for CONV01-α in Lu-PSMA pretreated Metastatic Castration-Resistant Prostate Cancer Patients at the 2026 ASCO Annual Meeting Businesswire
21-Apr-2026 Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details ACCESS Newswire
21-Apr-2026 NHI Announces Sale of NHC Portfolio for $560 Million ACCESS Newswire
21-Apr-2026 n-Lorem Foundation Announces the 50th Nano-rare Patient Receives Personalized ASO Medicine Businesswire
21-Apr-2026 Forlong Biotechnology to Present Clinical Data from the First-in-human Study for FL115 (IL-15 Superagonist) in US Patients with Advanced Solid Tumors at 2026 ASCO Annual Meeting Businesswire
21-Apr-2026 ImmunoScape Presents Data on Significant, Selective In-Vivo Expansion of Cell Therapy Product at AACR Annual Meeting Businesswire
21-Apr-2026 ValGenesis Partners with Westbourne to Expand Digital Validation Services for Life Sciences Businesswire
21-Apr-2026 Tortugas Neuroscience Launches with $106 Million to Advance Clinical Stage Pipeline Targeting New and Major Neurology and Neuropsychiatric Disorders Businesswire
21-Apr-2026 Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology Businesswire
21-Apr-2026 Schrödinger to Announce First Quarter 2026 Financial Results on May 5 Businesswire
21-Apr-2026 OmniAb to Report First Quarter 2026 Financial Results on May 7 Businesswire
21-Apr-2026 PHIL Invests in State-of-the-Art Cash Dispense Capabilities, Expanding Direct-to-Patient Fulfillment for Pharma Businesswire
21-Apr-2026 Charles River Highlights Effectiveness of VCGs in Toxicology Businesswire
21-Apr-2026 CellCarta Eliminates 9-Hours-Per-Week Regulatory Bottleneck with RegASK’s AI-Driven Intelligence Platform Businesswire
21-Apr-2026 Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs Businesswire
21-Apr-2026 Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease Prophylaxis Businesswire
21-Apr-2026 ConcertAI Introduces Cadence Suite, Delivering Industry Leading Visibility and Predictive Insights into the Patient’s Journey for Commercial Teams Businesswire
21-Apr-2026 Modulari-T Biosciences Names Tanya E. Borsuk, PhD, as Chief Executive Officer Businesswire
21-Apr-2026 Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum Businesswire